Highlights
AMEX: NBY       Novabay Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
0.608   -0.012 (1.94%)  0.60 - 0.629  396,400

Overview

 
Avg Volume (4 weeks):1,117,960
4 Weeks Range:0.60 - 0.84
4 Weeks Price Volatility (%):
3.33%
52 Weeks Range:0.24 - 1.94
52 Weeks Price Volatility (%):
21.65%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

NovaBay Pharmaceuticals Inc is a biopharmaceutical company. The company develops, manufactures, and markets anti-infective products for a multitude of uses. It is predominantly focused on commercializing prescription Avenova for the domestic eye care market in the United States. Avenova is the only eye care product formulated with proprietary, stable and pure form of hypochlorous acid (marketed as Neutrox). NovaBay develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. It has partnerships for NeutroPhase in the United States, as well as in other markets.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3337  5213  557  159 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 BLRX 1.98+0.50 
 AAPL 108.86-6.46 
 NIO 30.58-1.41 
 SQQQ 25.03+1.67 
 SPY 326.54-3.44 
 GE 7.42+0.05 
 TWTR 41.36-11.07 
 F 7.73-0.17 
 CCL 13.71+0.73 
 OAS 0.155-0.014